Activin and Inhibin

MAGL-IN-4 is an orally active, selective and reversible monoacylglycerol lipase (MAGL) inhibitor with an IC 50 of 6.2 nM. MAGL-IN-4 can penetrate the blood-brain barrier (BBB). MAGL-IN-4 enhances endocannabinoid signaling mostly by the increase in

MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC 50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL) , hormone sensitive lipase(HSL) , and fatty acid amide hydrolase(FAAH) respectively.Form:Solid.

MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC 50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL) , hormone sensitive lipase(HSL) , and fatty acid amide hydrolase(FAAH) respectively.Form:Solid.

MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC 50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL) , hormone sensitive lipase(HSL) , and fatty acid amide hydrolase(FAAH) respectively.Form:Solid.

MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC 50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL) , hormone sensitive lipase(HSL) , and fatty acid amide hydrolase(FAAH) respectively.Form:Solid.

MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC 50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL) , hormone sensitive lipase(HSL) , and fatty acid amide hydrolase(FAAH) respectively.Form:Solid.

MAL3-101 is a potent HSP70 allosteric inhibitor. MAL3-101 inhibits HSP70 ATPase activity by blocking Hsp40 co-chaperone interaction. MAL3-101 can be used for researching muscle invasive bladder cancer (MIBC)In VitroMAL3-101 (10 μM: 24, 48, 72 hours)

MAL3-101 is a potent HSP70 allosteric inhibitor. MAL3-101 inhibits HSP70 ATPase activity by blocking Hsp40 co-chaperone interaction. MAL3-101 can be used for researching muscle invasive bladder cancer (MIBC)In VitroMAL3-101 (10 μM: 24, 48, 72 hours)

Malabaricone B, a naturally occurring plant phenolic, is an orally active α-glucosidase inhibitor with an IC 50 of 63.7 µM. Malabaricone B has anticancer, antimicrobial, anti-oxidation and antidiabetic activities .In VitroMalabaricone B shows

Managlinat dialanetil (MB06322) is an orally bioavailable inhibitor of fructose 1,6-bisphosphatase (FBPase) for the treatment of type 2 diabetesIn VivoManaglinat dialanetil dose-dependently inhibits GNG as well as lower basal and postprandial blood

Managlinat dialanetil (MB06322) is an orally bioavailable inhibitor of fructose 1,6-bisphosphatase (FBPase) for the treatment of type 2 diabetesIn VivoManaglinat dialanetil dose-dependently inhibits GNG as well as lower basal and postprandial blood

MAO-B-IN-2 is a selective and competitive inhibitor of MAO-B and BChE with IC 50 values of 0.51 and 7.00 μM, respectively.Form:Solid.